| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SMLL.201300994 |
| P698 | PubMed publication ID | 23828664 |
| P2093 | author name string | Yong Yu | |
| Yuan-Di Zhao | |||
| Min Wan | |||
| Rong-Ying Zhang | |||
| Ming-Zhen Zhang | |||
| Rong-Na Yu | |||
| P2860 | cites work | Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor | Q30434397 |
| Peptide antisense nanoparticles | Q30484525 | ||
| Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. | Q33657117 | ||
| Peptide arrays for screening cancer specific peptides | Q33676152 | ||
| Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids | Q33862942 | ||
| Antisense oligonucleotides: promise and reality. | Q33939377 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis | Q36649655 | ||
| Inorganic nanoparticles as carriers of nucleic acids into cells | Q37039863 | ||
| siRNA conjugate delivery systems | Q37340480 | ||
| Endosomal escape pathways for delivery of biologicals | Q37809596 | ||
| Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. | Q37944929 | ||
| Quantum rods as nanocarriers of gene therapy. | Q38014158 | ||
| Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture | Q38300368 | ||
| Simultaneous detection of dual single-base mutations by capillary electrophoresis using quantum dot-molecular beacon probe | Q38339000 | ||
| siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing | Q38978041 | ||
| Target-cell-specific delivery, imaging, and detection of intracellular microRNA with a multifunctional SnO2 nanoprobe | Q39369810 | ||
| Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides | Q39374855 | ||
| Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism | Q39590246 | ||
| Preparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopy. | Q39719756 | ||
| Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis | Q39751536 | ||
| Distance-dependent metal-enhanced quantum dots fluorescence analysis in solution by capillary electrophoresis and its application to DNA detection | Q39752655 | ||
| Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. | Q39768994 | ||
| Clathrin-mediated endocytosis of quantum dot-peptide conjugates in living cells | Q39816950 | ||
| LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. | Q39930009 | ||
| Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots | Q39934812 | ||
| Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging | Q39969732 | ||
| Glutathione-mediated release of functional plasmid DNA from positively charged quantum dots | Q39996833 | ||
| Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. | Q40278223 | ||
| Preclinical evaluation of the breast cancer cell-binding peptide, p160. | Q40372690 | ||
| Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. | Q40462664 | ||
| Neuroblastoma tumor cell-binding peptides identified through random peptide phage display | Q40784037 | ||
| The chemistry and biology of oligonucleotide conjugates. | Q42011018 | ||
| Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. | Q42138120 | ||
| Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots. | Q43046464 | ||
| Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles | Q43966660 | ||
| Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots | Q45878053 | ||
| Targeted quantum dot conjugates for siRNA delivery | Q46077915 | ||
| Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting | Q46495707 | ||
| Modification of CdTe quantum dots as temperature-insensitive bioprobes | Q46678340 | ||
| Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. | Q50523941 | ||
| Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging. | Q50675322 | ||
| Quantum dot-antisense oligonucleotide conjugates for multifunctional gene transfection, mRNA regulation, and tracking of biological processes. | Q50691207 | ||
| Bioconjugate recognition molecules to quantum dots as tumor probes. | Q50967108 | ||
| Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. | Q54950226 | ||
| Engineering Particles for Therapeutic Delivery: Prospects and Challenges | Q57645029 | ||
| P433 | issue | 24 | |
| P921 | main subject | folic acid | Q127060 |
| quantum dot | Q1133068 | ||
| P304 | page(s) | 4183-4193 | |
| P577 | publication date | 2013-07-05 | |
| P1433 | published in | Small | Q3486838 |
| P1476 | title | Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide | |
| P478 | volume | 9 |
| Q38174527 | Characterization and separation of semiconductor quantum dots and their conjugates by capillary electrophoresis |
| Q35134239 | Continuing progress toward controlled intracellular delivery of semiconductor quantum dots |
| Q47107037 | Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases? |
| Q28394225 | Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy |
| Q41843285 | Insulin-Based Regulation of Glucose-functionalized Nanoparticle Uptake in Muscle Cells. |
| Q35292124 | Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells |
| Q42797947 | Multifunctional quantum dot-polypeptide hybrid nanogel for targeted imaging and drug delivery |
| Q64929129 | Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. |
| Q92504280 | Nitrogen doped carbon quantum dots demonstrate no toxicity under in vitro conditions in a cervical cell line and in vivo in Swiss albino mice |
| Q47840447 | Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis |
| Q37012929 | Plant derived edible nanoparticles as a new therapeutic approach against diseases |
| Q104076005 | Plant exosome like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms |
| Q35137821 | Quantum dot tailored to single wall carbon nanotubes: a multifunctional hybrid nanoconstruct for cellular imaging and targeted photothermal therapy |
| Q39245957 | Recent advances in peptide nucleic acid for cancer bionanotechnology |
| Q36500830 | Targeting and retention enhancement of quantum dots decorated with amino acids in an invertebrate model organism |
Search more.